Since 2006, with the support of Pfizer Inc, the Royal Society has offered the Pfizer Award to recognise research scientists based in Africa who are making an innovative contribution to the biological sciences, including basic medical science, which contributes significantly to capacity building in Africa.
The Award consists of an £11,000 grant towards a research project that is linked to an African centre of scientific excellence, which would normally be a university, or equivalent research centre, and a personal prize of £1,000.
The Award is presented at a ceremony at the Royal Society. A seminar is also held to celebrate the work of the recipient at which he/she will give a talk about their research and how the Award will affect their progress.
The call for nominations has now closed.
The recipient is chosen by the Council of the Royal Society on the recommendation of the Biological Sciences Awards Committees. Nominations are valid for one year.
Please read the terms and conditions for this award (PDF) and the general terms and conditions (PDF) for your information.
In 2015, to mark the 10th anniversary of the Royal Society Pfizer Award, the programme was expanded to allow two awards: an Early Career Award for a research scientist at an early stage of his or her career showing exceptional promise; and an Advanced Award for an experienced top-level researcher that has made a significant and sustained contribution in both research and leadership.
Dr Gordon A Awandare was awarded the 2015 Pfizer Early Career Award for his achievements in molecular and cellular studies of malaria, including how malaria parasites invade red blood cells and cause disease. Professor Jean-Jacques Muyembe-Tamfum was awarded the 2015 Pfizer Advanced Award for his seminal work on viral haemorrhagic fevers, including Ebola, generating the foundation of our understanding of the epidemiology, clinical manifestations and control of outbreaks of these viral infections.
See full list of all past winners of the Royal Society Pfizer Award.
This award is supported by Pfizer Inc.